Drug Candidate Selection

NAEJA has assembled a multidisciplinary group of scientists with many years of experience in the drug discovery and development. Prior to selecting a Candidate compound for clinical development, NAEJA's teams will work with your team to evaluate your most promising Lead compounds. The selection criteria will include, but not be limited to:

• Efficacy (in vitro and in vivo)
• Physio-chemical characteristics (Solubility and Stability)
• Ease of synthesis
• Scale-up synthetic methods
• Pharmacokinetics and metabolism
• Safety

NAEJA's expertise also covers a broad range of chemical classes ranging from Cancer, CVS, CNS, Inflammatory, to Infective agents. This expertise was developed by being involved in such disease areas over the past twenty or so years. NAEJA's clients being them either large pharmaceutical companies or small biotechnology companies attest to NAEJA's capabilities of handling the most difficult synthetic chemistry schemes and being able to develop schemes where no established schemes are available. NAEJA will utilize such wide expertise to prepare your Final Compounds, Reference (benchmark) Compounds, Intermediates or Starting Material.